Denosumab more effective than risedronate in glucocorticoid-induced osteoporosis – Healio

MedPage TodayDenosumab more effective than risedronate in glucocorticoid-induced osteoporosisHealioAdults with a history of glucocorticoid-induced osteoporosis assigned to therapy with the monoclonal antibody denosumab experienced a greater increase in bone mineral density at the lumber spine and total hip at 12 months vs. similar patients assigned …Benefits, Drawbacks to Denosumab Tx in ESRDMedPage Todayall 2 news articles

Source:: Osteoporosis Feed

      

Last modified: April 12, 2018